144 related articles for article (PubMed ID: 30882064)
1. Prediction of Ischemic Events after Percutaneous Coronary Intervention: Thrombelastography Profiles and Factor XIIIa Activity.
Kreutz RP; Schmeisser G; Schaffter A; Kanuri S; Owens J; Maatman B; Sinha A; von der Lohe E; Breall JA
TH Open; 2018 Apr; 2(2):e173-e181. PubMed ID: 30882064
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrel.
Kreutz RP; Owens J; Lu D; Nystrom P; Jin Y; Kreutz Y; Desta Z; Flockhart DA
Platelets; 2015; 26(4):358-63. PubMed ID: 24833046
[TBL] [Abstract][Full Text] [Related]
3. Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes.
Lu D; Owens J; Kreutz RP
Thromb Res; 2013 Aug; 132(2):e94-8. PubMed ID: 23920429
[TBL] [Abstract][Full Text] [Related]
4. Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography.
Maatman BT; Schmeisser G; Kreutz RP
J Diabetes Res; 2018; 2018():4543065. PubMed ID: 29507861
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
Kreutz RP; Owens J; Breall JA; Lu D; von der Lohe E; Bolad I; Sinha A; Flockhart DA
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):321-6. PubMed ID: 23429252
[TBL] [Abstract][Full Text] [Related]
6. Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.
Lawson PJ; Moore HB; Moore EE; Gerich ME; Stettler GR; Banerjee A; Schulick RD; Nydam TL
J Surg Res; 2018 Nov; 231():54-61. PubMed ID: 30278969
[TBL] [Abstract][Full Text] [Related]
7. Thrombelastography maximal clot strength could predict one-year functional outcome in patients with ischemic stroke.
Yao X; Dong Q; Song Y; Wang Y; Deng Y; Li Y
Cerebrovasc Dis; 2014; 38(3):182-90. PubMed ID: 25300785
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and platelet contributions to clot formation: implications for trauma resuscitation and thromboprophylaxis.
Kornblith LZ; Kutcher ME; Redick BJ; Calfee CS; Vilardi RF; Cohen MJ
J Trauma Acute Care Surg; 2014 Feb; 76(2):255-6; discussion 262-3. PubMed ID: 24458031
[TBL] [Abstract][Full Text] [Related]
9. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
[TBL] [Abstract][Full Text] [Related]
10. Platelet-fibrin clot strength measured by thromboelastography could predict hypercoagulability and antiplatelet effects in patients after percutaneous coronary intervention.
Yan XQ; Zhang C; Shi HY; Kong LC; Liu L; Gu ZC; Zhu Q
Ann Palliat Med; 2021 Mar; 10(3):2448-2457. PubMed ID: 33440968
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of thrombelastographic platelet-mapping in healthy cats.
Blois SL; Banerjee A; Wood RD
Vet Clin Pathol; 2012 Jun; 41(2):223-7. PubMed ID: 22452748
[TBL] [Abstract][Full Text] [Related]
12. Clot Formation Is Associated With Fibrinogen and Platelet Forces in a Cohort of Severely Injured Emergency Department Trauma Patients.
White NJ; Newton JC; Martin EJ; Mohammed BM; Contaifer D; Bostic JL; Brophy GM; Spiess BD; Pusateri AE; Ward KR; Brophy DF
Shock; 2015 Aug; 44 Suppl 1(0 1):39-44. PubMed ID: 25643013
[TBL] [Abstract][Full Text] [Related]
13. Clinical applicability of rapid thrombelastography and functional fibrinogen thrombelastography to adult liver transplantation.
Yang Lu S; Tanaka KA; Abuelkasem E; Planinsic RM; Sakai T
Liver Transpl; 2014 Sep; 20(9):1097-105. PubMed ID: 24889921
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic evaluations of clot morphology during thrombelastography.
Kawasaki J; Katori N; Kodaka M; Miyao H; Tanaka KA
Anesth Analg; 2004 Nov; 99(5):1440-1444. PubMed ID: 15502045
[TBL] [Abstract][Full Text] [Related]
15. Systemic central venous oxygen saturation is associated with clot strength during traumatic hemorrhagic shock: A preclinical observational model.
White NJ; Martin EJ; Shin Y; Brophy DF; Diegelmann RF; Ward KR
Scand J Trauma Resusc Emerg Med; 2010 Dec; 18():64. PubMed ID: 21138566
[TBL] [Abstract][Full Text] [Related]
16. Relationship between thromboelastography and long-term ischemic events as gauged by the response to clopidogrel in patients undergoing elective percutaneous coronary intervention.
Hou X; Han W; Gan Q; Liu Y; Fang W
Biosci Trends; 2017 May; 11(2):209-213. PubMed ID: 28320981
[TBL] [Abstract][Full Text] [Related]
17. Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factor.
Epstein KL; Brainard BM; Lopes MA; Barton MH; Moore JN
J Vet Emerg Crit Care (San Antonio); 2009 Feb; 19(1):96-101. PubMed ID: 19691590
[TBL] [Abstract][Full Text] [Related]
18. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
[TBL] [Abstract][Full Text] [Related]
19. Hypercoagulation assessed by thromboelastography is neither related to infarct size nor to clinical outcome after primary percutaneous coronary intervention.
Dridi NP; Lønborg JT; Radu MD; Clemmensen P; Engstrøm T; Kelbæk H; Jørgensen E; Helqvist S; Saunamäki K; Christensen TH; Baeres FM; Johansson PI; Holmvang L
Clin Appl Thromb Hemost; 2014 Nov; 20(8):825-31. PubMed ID: 23613040
[TBL] [Abstract][Full Text] [Related]
20. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study.
Ostrowski SR; Sørensen AM; Larsen CF; Johansson PI
Scand J Trauma Resusc Emerg Med; 2011 Oct; 19():64. PubMed ID: 22029598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
